Hi everyone,
A handful of studies this week landed in that sweet spot I love, big effects from changes that cost almost nothing. People who did the exact same workout, but timed it to their own body clock, nearly doubled the drop in their blood pressure. A routine pharmacy shot most of us think of only for shingles was linked to a third less dementia. And eating a bowl of grapes a day measurably helped skin stand up to the sun.
On the podcast, I sat down with my colleague Dr. Ronald Talis, a podiatrist, to talk about feet, the one part of the body doctors rarely examine, and why a cold or dusky toe can be one of the earliest warning signs of heart disease.
Let’s get into it.
This Week’s Podcast Spotlight
Episode 53: The Heart-Foot Connection: Why Your Feet Are Warning You About Heart Disease, with Dr. Ronald Talis
I wanted to do this episode because the foot is the one part of the body doctors rarely look at, myself included for most of my career, and yet it may be one of the earliest places that heart and metabolic disease quietly announce themselves. I sat down with Dr. Ronald Talis, a board certified podiatrist who operates alongside me here in North Carolina, and he completely reframed how I think about the 26 bones, 30 plus joints, and more than 100 muscles packed into each foot. We get into why pronation is normal rather than a defect, why a $150 motion control shoe is often oversold, why plantar fasciitis is rarely actual inflammation, and the genuinely fascinating use of a blistering beetle extract to get your immune system to hunt down warts.
What stuck with me most was the idea of the foot as a canary in the coal mine. The blood vessels in your toes are the smallest and the farthest from your heart, which is why they are often the first place trouble shows up.
Three things that stood out from this conversation:
- A cold, dusky, darkening, or hairless toe can be one of the earliest signs of peripheral arterial disease, which strongly predicts coronary artery disease. If you have diabetes, take your shoes and socks off at every single doctor visit, because loss of protective sensation is the silent setup for ulcers and amputation.
- Shoes act like casts. Just as a six week cast withers the muscles underneath it, a lifetime in supportive shoes lets the small intrinsic muscles of the foot quietly atrophy. Spending controlled time barefoot, and balancing on one leg on a pillow with your eyes closed, is one of the simplest ways to rebuild foot strength and balance.
- Plantar fasciitis is usually not inflammation at all. It is mostly a flexibility and strength problem, which is why stretching the Achilles and heel cord and strengthening the foot tend to help more than reaching for anti inflammatories.
If you have ever been told you over pronate, struggled with stubborn heel pain, or just never gave your feet a second thought, this conversation will change how you see them.
This Week in Health Science
Here is what stood out from the research this week. These studies fascinated me, and I think you will find them practically useful.
Same Workout, Nearly Double the Blood Pressure Drop
I spend a lot of my day telling patients to exercise more, and it is a hard sell. So I loved this one, because the people in it did not do more, they just did the same workout at the time of day that matched their natural body clock. Morning people trained in the morning, night owls trained in the evening, and over 12 weeks they cut their top blood pressure number by 10.8 mmHg, nearly twice the 5.5 mmHg drop in the mismatched group. They also slept better and saw bigger improvements in blood sugar and cholesterol from the exact same effort. It was a small, short trial of 150 adults, so I would not abandon a routine that already works for you, but if you have any flexibility in your schedule, timing is a free lever worth pulling.
Key finding: Timed to a person’s own body clock, the identical workout lowered systolic blood pressure by 10.8 mmHg, nearly double the 5.5 mmHg drop seen when the same exercise was done at a mismatched time.
The Sleep Window Where Your Whole Body Ages the Slowest
Patients ask me constantly how much sleep they really need, and for years the honest answer was a vague seven to nine hours. This study of about half a million UK Biobank adults tightens that up considerably. Using 23 different biological aging clocks built from brain and body scans, blood proteins, and metabolites, researchers found a clean U-shape, with aging slowest between 6.4 and 7.8 hours a night and faster on both ends. What struck me is that the pattern held across 17 different organ systems, so this is a whole-body signal, not just brain maintenance. I would not read it as proof that more sleep is bad, since long sleep is often a symptom of something else like sleep apnea or depression, but if you are regularly under six hours, treat that as a real medical issue worth fixing.
Key finding: Across 17 organ systems in roughly 500,000 adults, sleeping 6.4 to 7.8 hours a night tracked with the slowest biological aging, while less than 6 or more than 8 hours tracked with faster aging and higher rates of disease and death.
A Bowl of Grapes a Day Helped Skin Stand Up to the Sun
This is the kind of finding that sounds too good to be true, so I read it carefully. Healthy adults ate the equivalent of three servings of whole grapes a day for two weeks, and afterward their skin showed measurable changes in genes that build its protective outer barrier. When researchers then exposed that skin to UV light, it produced significantly less of a key marker of oxidative damage. What got my attention was the consistency, because skin biology is famously personal, and yet the protective signal showed up in every single participant. This is an early mechanistic study, not proof that grapes prevent sunburn or wrinkles, and it is no replacement for sunscreen, but grapes are cheap, safe, and tasty, so the bar to try is low.
Key finding: After two weeks of about three servings of whole grapes a day, skin shifted toward a stronger barrier and produced significantly less of an oxidative damage marker after UV exposure, in every participant tested.
A Routine Pharmacy Shot Linked to a Third Less Dementia
We have very few things that move the needle on dementia at all, which is why this one genuinely excited me. Researchers compared about 500,000 older adults who completed the two-dose Shingrix shingles vaccine with more than a million carefully matched unvaccinated adults, and over three years the vaccinated group developed about a third fewer new cases of dementia. Alzheimer’s risk was 28 percent lower and vascular dementia 33 percent lower, and the pattern held in every subgroup the team checked. I want to be honest that this is observational, and people who get vaccinated tend to be more engaged with their health in general, but this is now the third or fourth large study pointing the same way. On top of the well-established benefit of avoiding a miserable shingles rash, that is a strong reason to have the conversation with your doctor.
Key finding: Older adults who completed the two-dose Shingrix series had a 33 percent lower risk of new dementia over three years, with Alzheimer’s risk 28 percent lower and vascular dementia 33 percent lower, in a Medicare study of more than 1.5 million people.
The Weight-Loss Drug Tied to Far Better Breast Cancer Survival
GLP-1 drugs like Ozempic keep turning up in unexpected places, and this is one of the more striking. In a database of 841,831 women with early-stage breast cancer, those with obesity who took a GLP-1 drug had a 65 percent lower risk of dying over 10 years and a 56 percent lower risk of the cancer returning, with even larger numbers in women who also had type 2 diabetes. I will be straight with you, an effect that large makes me skeptical, because numbers like these almost always shrink once a real randomized trial is run. But the biology is plausible, since obesity and high insulin are known drivers of breast cancer growth, and GLP-1 drugs lower weight, blood sugar, and insulin all at once. For now I read this as a promising bonus for women who already have a reason to take these drugs, not a reason to start one to fight cancer.
Key finding: Among women with obesity and early-stage breast cancer, GLP-1 drug use was linked to a 65 percent lower risk of death and a 56 percent lower risk of recurrence over 10 years, though this is observational and the true effect is likely smaller.
My book, 2mm, is almost here. It is the story of seven years inside the operating room, where every decision is measured in millimeters and every millimeter matters. If you want to be the first to know when it is available, leave your email at 2mmbook.com.
Stay curious. Stay skeptical. And stay healthy.
Dr Kumar